Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06481774 · ClinicalTrials.gov registry record · NA
Promoting Access, Resources and Treatment Through Novel and Equitable Solutions for Cancer Care
A NA study of Cancer, sponsored by Case Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 375
- Enrollment target
- 1
- Study location
NCT06481774: Recruiting NA study of Cancer, sponsored by Case Comprehensive Cancer Center.
NCT06481774 is a NA study of Cancer that is actively recruiting participants, run by Case Comprehensive Cancer Center. The registered enrollment target is 375 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06481774, a NA study of Cancer, is actively recruiting participants, sponsored by Case Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 375 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to evaluate a novel, integrated approach to providing navigation services to improve cancer outcomes and quality of life.
Primary Outcome
Participant distress screening assessment tool is a list of questionnaire with a scale from 0-10, where 0 is none and 10 is extreme distress
Conditions Studied
Interventions
- BEHAVIORAL CONNECT platform
Study Locations (1)
Ohio
- Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375 participants |
| Start Date | 2024-07-30 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT06481774 shows while recruiting
NCT06481774 is an interventional study that assigns participants to a tested intervention. The registered 375 participants enrollment target is mid-sized for trials with a published cap, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which CONNECT platform is the first listed.
NCT06481774 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06481774 about?
NCT06481774 is a clinical study titled "Promoting Access, Resources and Treatment Through Novel and Equitable Solutions for Cancer Care". The purpose of this research is to evaluate a novel, integrated approach to providing navigation services to improve cancer outcomes and quality of life.
What is the current status of trial NCT06481774?
This trial is currently recruiting. It is a NA study. The enrollment target is 375 participants. The study started on 2024-07-30. Estimated completion is 2027-06-30.
What conditions does trial NCT06481774 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT06481774?
The interventions under investigation include: CONNECT platform (BEHAVIORAL).
Who is sponsoring clinical trial NCT06481774?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06481774 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06481774's enrollment target sits among peer trials
375 158th of 615 higher than 457 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04059172 · 375 participants · Early Phase 1
Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain Management
- NCT04134923 · 375 participants
Imaging Biomarkers in Preclinical and Symptomatic AD
- NCT04569747 · 375 participants · Phase 2
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
- NCT04571658 · 375 participants · NA
NEPTUNE Match Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI